๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—†
Updated 04 Jul 2026 ยท HPRA open data

Tozinameran - Medicines in Ireland

12 authorised products containing Tozinameran, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 12 authorised medicines
MedicineActive substanceLicence holderStatus
Comirnaty
EU/1/20/1528/001
Tozinameran BioNTech Manufacturing GmbH โ€”
Comirnaty
EU/1/20/1528/002-003
Tozinameran BioNTech Manufacturing GmbH โ€”
Comirnaty
EU/1/20/1528/004-005
Tozinameran BioNTech Manufacturing GmbH โ€”
Comirnaty
EU/1/20/1528/010
Tozinameran BioNTech Manufacturing GmbH โ€”
Comirnaty
EU/1/20/1528/028-031
Tozinameran BioNTech Manufacturing GmbH โ€”
COMIRNATY Omicron XBB.1.5 10 mcg injection
EU/1/20/1528/024
Tozinameran BioNTech Manufacturing GmbH โ€”
COMIRNATY Omicron XBB.1.5 10 micrograms/dose concentrate for dispersion for injection children 5 to 11 years
EU/1/20/1528/021
Tozinameran BioNTech Manufacturing GmbH โ€”
COMIRNATY Omicron XBB.1.5 10 micrograms/dose dispersion for injection children 5 to 11 years
EU/1/20/1528/022
Tozinameran BioNTech Manufacturing GmbH โ€”
COMIRNATY Omicron XBB.1.5 10 micrograms/dose dispersion for injection children 5 to 11 years
EU/1/20/1528/023
Tozinameran BioNTech Manufacturing GmbH โ€”
COMIRNATY Omicron XBB.1.5 30 micrograms/dose dispersion for injection adults and adolescents from 12 years
EU/1/20/1528/018
Tozinameran BioNTech Manufacturing GmbH โ€”
COMIRNATY Omicron XBB.1.5 30 micrograms/dose dispersion for injection adults and adolescents from 12 years
EU/1/20/1528/019
Tozinameran BioNTech Manufacturing GmbH โ€”
COMIRNATY Omicron XBB.1.5 30 micrograms/dose dispersion for injection adults and adolescents from 12 years
EU/1/20/1528/020
Tozinameran BioNTech Manufacturing GmbH โ€”
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 12 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.